660 / 1363
FDA-AUA-SUO workshop 2015
• Criteria for patient selection remain debatable
• Long term cancer control remains to be
established in properly designed and well-
performed prospective clinical trials
• Concerns
– excessive, unnecessary use, and
– inadequate treatment
Jarow et al.